Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

Genetic Profiling Transforms Cancer Treatment Trials

“It’s a new paradigm of trial design for cancer,” said Dr. Esteva. “Going forward, all major drug trials should be designed” to include genetic analyses. Dr. Robert L. Becker, Jr. Dr. … Continue reading

December 12, 2013

Use of Cervical Mucus to Screen for Gynecological Malignancies – A Pilot Study

“The results of this study provide evidence that DNA from precursor lesions of high grade ovarian, fallopian tube and endometrial carcinomas can be detected in cervical mucus.” Ihab Lamzabi, Lela Buckingham, … Continue reading

December 12, 2013

In Israel, a Push to Screen for Cancer Gene Leaves Many Conflicted

“Women identified as mutation carriers are showered with resources for early detection and prevention. These women’s risk for developing breast cancer ranges from 45 to 65 percent or higher, depending on family … Continue reading

December 12, 2013

The Carer Support Needs Assessment Tool for Use in Palliative and End-of-Life Care at Home: A Validation Study

“… study testing a tool that is practical for clinical use. Nurses frequently are in a position of needing to quickly assess caregiver needs and to coordinate the multiple disciplines and … Continue reading

December 12, 2013

New Drug Shown to Potentially Extend Life in Women with Advanced Ovarian Cancer

“In women whose ovarian cancer has returned and treated with the standard platinum-based chemotherapy it normally takes eight to nine months before the cancer starts to grow again. But when treated with … Continue reading

December 12, 2013

Many Women with Cancer Not Told About Impaired Fertility Risk

“Only 60% of women with uterine cancers and 42% of women with ovarian cancers were told about the effects of treatment on fertility, despite having cancers of the reproductive system.” IMNG … Continue reading

December 12, 2013

Neuropathic Pain Resulting From Pelvic Masses

“Tumor bulk reduction with appropriate anti-neoplastic therapies. Medication management of pain and concurrent non-pain symptoms. Analgesic medications include antidepressants, anticonvulsants, and opioids. Consideration of symptom management in the context of prognosis, functional goals, … Continue reading

December 12, 2013

American College of Radiology Appropriateness Criteria® Management of Vaginal Cancer

“The majority of primary vaginal cancers are squamous cell carcinomas, which are frequently associated with human papillomavirus infection.[2,3] Given the rarity of this disease, prospective trials of patients with vaginal cancer have … Continue reading

December 12, 2013

Update on the Management and the Role of Intraperitoneal Chemotherapy for Ovarian Cancer

“The most important prognostic factor for ovarian cancer survival is the ability to achieve optimal cytoreduction with no residual disease.” Teo MC. Curr Opin Obstet Gynecol. 2013 Nov 15. [Epub ahead … Continue reading

December 12, 2013

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada